Mejorando las directrices para el consentimiento informado
i-CONSENT, financiado por el programa H2020 de la Unión Europea, tiene como objetivo mejorar la información que los pacientes reciben de los estudios clínicos. En el marco del proyecto, se elaborarán una serie de recomendaciones para mejorar el proceso de Consentimiento Informado, incluyendo a la población vulnerable y bajo una perspectiva de género, ayudándose de las nuevas tecnologías.
Implications of COVID-19 for informed consent
Conclusions on the sessions organized by our partner LUMSA University Following the sessions organised to discuss informed consent for clinical trials in the context of an emergency setting, find a compilation of each meeting's main conclusions. Research protocols and...
Conversations on informed consent in the context of the COVID-19
i-CONSENT organizes a series of workshops to discuss informed consent for clinical trials in the context of an emergency setting i-CONSENT partner, LUMSA University, has organized a series of internal online workshops to discuss informed consent in the...
Informed consent in the pandemic context: between bioethics and biolaw
Project publishes and article describing informed consent in biomedical research in the pandemic context in the Journal of BioLaw: Rivista di Biodiritto Clinical research is world widely speeding in order to identify as soon as possible COVID-19 treatment and vaccine....
Visita nuestro Twitter y disfruta de nuestro contenido actualizado!
@ICONSENTEU
Article | Find a compilation of the conclusions following our sessions organized to discuss #informedconsent for #clinicaltrials in the context of #COVID19. First meeting about research protocols and COVID-19: adequate patient information
🗯️ #iCONSENT
https://buff.ly/3nYSrJc